WuXi teams up with Gilead; PharPoint expands its HQ;

> WuXi PharmaTech ($WX) signed a deal to work with Gilead Sciences ($GILD) on R&D in its native China. News

> CRO PharPoint Research expanded its North Carolina headquarters to account for "stable growth of new employees," the company said. More

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.